DJIA 16,642.62 27.81 0.17%
NASDAQ 4,427.32 7.84 0.18%
S&P 500 1,943.58 2.30 0.12%
market minute promo

Nektar Therapeutics (NASDAQ: NKTR)

12.92 0.28 (2.22%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

NKTR $12.92 2.22%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $12.64
Previous Close $12.64
Daily Range $12.51 - $12.88
52-Week Range $8.87 - $15.34
Market Cap $1.6B
P/E Ratio -10.71
Dividend (Yield) $0.00 (0.0%)
Volume 121,450
Average Daily Volume 1,591,431
Current FY EPS -$0.65

Sector

Healthcare

Industry

Drugs

Nektar Therapeutics (NKTR) Description

A biopharmaceutical company which develops breakthrough products that make a difference in patients' lives. It creates differentiated, innovative products by applying its platform technologies to established or novel medicines. Website: http://www.nektar.com/

News & Commentary

Can Anything Derail Salix Pharmaceuticals?

Expanded labeling for the sub-q form of Relistor could add $100 million in revenue, but doesn't change the business to a large extent

Nektar Therapeutics (NKTR) Weak On High Volume Today

Update: AstraZeneca Moves Closer To EU Approval For Moventig

Nektar/AstraZeneca's Moventig a Step Closer to EU Approval - Analyst Blog

Interesting NKTR Put And Call Options For May 2015

Sector Update: Health-Care Stocks Mixed Pre-Market

Nektar Therapeutics (NKTR) Shares Cross Below 200 DMA

Salix' s Xifaxan 550 sNDA Under Review, Response by Feb 28 - Analyst Blog

Salix' s Xifaxan 550 sNDA Under Review, Response by Feb 28 - Analyst Blog

Nektar Presents Positive Preclinical Data On Oral, Peripherally-Acting Kappa Agonist Molecules At 20

Nektar Presents Positive Preclinical Data On Oral, Peripherally-Acting Kappa Agonist Molecules At 2014 American Academy Of Pain Management Meeting

AstraZeneca's Constipation Drug Movantik Gets FDA Nod - Analyst Blog

How Will AstraZeneca (AZN) and Nektar Therapeutics (NKTR) Stock Reacy to FDA's Movantik Approval?

See More NKTR News...

NKTR's Top Competitors

NKTR $12.92 (2.22%)
Current stock: NKTR
TMO $113.98 (-3.59%)
Current stock: TMO
ILMN $186.65 (3.95%)
Current stock: ILMN
WAT $106.16 (-0.94%)
Current stock: WAT